Ontology type: schema:ScholarlyArticle
1996-10
AUTHORSPeter C. Willsher, Jayne Beaver, Sarah Pinder, Jane A. Bell, Ian O. Ellis, Roger W. Blamey, John F. R. Robertson
ABSTRACTThe tissue expression of c-erbB-2 protein in breast cancer is a marker of poor prognosis in a number of studies. More recently it has also been suggested that c-erbB-2 expression may predict response to systemic therapy in patients with advanced breast cancer. The measurement of c-erbB-2 protein in the serum of breast cancer patients has now been reported, but the significance of this finding is not clear. In this study an ELISA assay was used to measure c-erbB-2 in the sera of 23 normal controls, 46 benign breast disease patients, and 119 breast cancer patients. Elevated serum c-erbB-2 protein levels were detected in 13% (3/23) of normal controls, 15% (7/46) of benign disease patients, 15% (7/46) of Stage I/II patients, 26% (9/35) of Stage III patients, and 21% (8/38) of Stage IV patients. The tissue expression of the c-erbB-2 protein showed no association with detection of the serum c-erbB-2 protein (p = 0.31). In the 67 Stage III and IV patients who had assessable disease the presence of the c-erbB-2 protein in the serum bore no relationship to response to hormonal therapy (p = 0.71). Serum detection of the c-erbB-2 protein in Stage I/II patients predicted for a worsening of both survival outcome (p = 0.002) and disease free interval (p = 0.002). A worse outcome was also seen for the Stage III patients (p = 0.04) and Stage IV patients, although the latter did not reach statistical significance (p = 0.27). This study found that the presence of c-erbB-2 in the serum of breast cancer patients was of prognostic significance for all stages of disease. More... »
PAGES251-255
http://scigraph.springernature.com/pub.10.1007/bf01806813
DOIhttp://dx.doi.org/10.1007/bf01806813
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1048762042
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/8883967
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Biomarkers, Tumor",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Breast Diseases",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Breast Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Enzyme-Linked Immunosorbent Assay",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Neoplasm Proteins",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Neoplasm Staging",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Prognosis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Receptor, ErbB-2",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Reference Values",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Nottingham City Hospital",
"id": "https://www.grid.ac/institutes/grid.412920.c",
"name": [
"Professorial Department of Surgery, City Hospital, Hucknall Road, NG5 1PB, Nottingham, UK"
],
"type": "Organization"
},
"familyName": "Willsher",
"givenName": "Peter C.",
"id": "sg:person.01347210454.77",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347210454.77"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Nottingham City Hospital",
"id": "https://www.grid.ac/institutes/grid.412920.c",
"name": [
"Department of Histopathology, City Hospital, Nottingham, UK"
],
"type": "Organization"
},
"familyName": "Beaver",
"givenName": "Jayne",
"id": "sg:person.0632072210.15",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632072210.15"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Nottingham City Hospital",
"id": "https://www.grid.ac/institutes/grid.412920.c",
"name": [
"Department of Histopathology, City Hospital, Nottingham, UK"
],
"type": "Organization"
},
"familyName": "Pinder",
"givenName": "Sarah",
"id": "sg:person.014576043464.09",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014576043464.09"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Nottingham City Hospital",
"id": "https://www.grid.ac/institutes/grid.412920.c",
"name": [
"Department of Histopathology, City Hospital, Nottingham, UK"
],
"type": "Organization"
},
"familyName": "Bell",
"givenName": "Jane A.",
"id": "sg:person.016203754172.26",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016203754172.26"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Nottingham City Hospital",
"id": "https://www.grid.ac/institutes/grid.412920.c",
"name": [
"Department of Histopathology, City Hospital, Nottingham, UK"
],
"type": "Organization"
},
"familyName": "Ellis",
"givenName": "Ian O.",
"id": "sg:person.01054612302.65",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054612302.65"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Nottingham City Hospital",
"id": "https://www.grid.ac/institutes/grid.412920.c",
"name": [
"Professorial Department of Surgery, City Hospital, Hucknall Road, NG5 1PB, Nottingham, UK"
],
"type": "Organization"
},
"familyName": "Blamey",
"givenName": "Roger W.",
"id": "sg:person.015650304144.58",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015650304144.58"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Nottingham City Hospital",
"id": "https://www.grid.ac/institutes/grid.412920.c",
"name": [
"Professorial Department of Surgery, City Hospital, Hucknall Road, NG5 1PB, Nottingham, UK"
],
"type": "Organization"
},
"familyName": "Robertson",
"givenName": "John F. R.",
"id": "sg:person.07764637207.20",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07764637207.20"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/bf01961241",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1002229729",
"https://doi.org/10.1007/bf01961241"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf01212719",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1005157350",
"https://doi.org/10.1007/bf01212719"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf01212719",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1005157350",
"https://doi.org/10.1007/bf01212719"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/1097-0142(197703)39:3<1289::aid-cncr2820390340>3.0.co;2-f",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1011360956"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bjc.1994.387",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021569604",
"https://doi.org/10.1038/bjc.1994.387"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bjc.1994.387",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021569604",
"https://doi.org/10.1038/bjc.1994.387"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bjc.1991.101",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1023327364",
"https://doi.org/10.1038/bjc.1991.101"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bjc.1991.101",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1023327364",
"https://doi.org/10.1038/bjc.1991.101"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3109/02841869509094014",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1038026586"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf01961242",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1045749770",
"https://doi.org/10.1007/bf01961242"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s0959-8049(05)80215-1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1046817550"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1126/science.3798106",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1062621480"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1075758988",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1079800982",
"type": "CreativeWork"
}
],
"datePublished": "1996-10",
"datePublishedReg": "1996-10-01",
"description": "The tissue expression of c-erbB-2 protein in breast cancer is a marker of poor prognosis in a number of studies. More recently it has also been suggested that c-erbB-2 expression may predict response to systemic therapy in patients with advanced breast cancer. The measurement of c-erbB-2 protein in the serum of breast cancer patients has now been reported, but the significance of this finding is not clear. In this study an ELISA assay was used to measure c-erbB-2 in the sera of 23 normal controls, 46 benign breast disease patients, and 119 breast cancer patients. Elevated serum c-erbB-2 protein levels were detected in 13% (3/23) of normal controls, 15% (7/46) of benign disease patients, 15% (7/46) of Stage I/II patients, 26% (9/35) of Stage III patients, and 21% (8/38) of Stage IV patients. The tissue expression of the c-erbB-2 protein showed no association with detection of the serum c-erbB-2 protein (p = 0.31). In the 67 Stage III and IV patients who had assessable disease the presence of the c-erbB-2 protein in the serum bore no relationship to response to hormonal therapy (p = 0.71). Serum detection of the c-erbB-2 protein in Stage I/II patients predicted for a worsening of both survival outcome (p = 0.002) and disease free interval (p = 0.002). A worse outcome was also seen for the Stage III patients (p = 0.04) and Stage IV patients, although the latter did not reach statistical significance (p = 0.27). This study found that the presence of c-erbB-2 in the serum of breast cancer patients was of prognostic significance for all stages of disease.",
"genre": "research_article",
"id": "sg:pub.10.1007/bf01806813",
"inLanguage": [
"en"
],
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1092777",
"issn": [
"0167-6806",
"1573-7217"
],
"name": "Breast Cancer Research and Treatment",
"type": "Periodical"
},
{
"issueNumber": "3",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "40"
}
],
"name": "Prognostic significance of serum c-erbB-2 protein in breast cancer patients",
"pagination": "251-255",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"e84b008ada7f14d3f42a1e027d2035cf39b6a61d3091bd825108c1b9e3023751"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"8883967"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"8111104"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/bf01806813"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1048762042"
]
}
],
"sameAs": [
"https://doi.org/10.1007/bf01806813",
"https://app.dimensions.ai/details/publication/pub.1048762042"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-11T10:39",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000349_0000000349/records_113679_00000002.jsonl",
"type": "ScholarlyArticle",
"url": "http://link.springer.com/10.1007/BF01806813"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf01806813'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf01806813'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf01806813'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf01806813'
This table displays all metadata directly associated to this object as RDF triples.
192 TRIPLES
21 PREDICATES
51 URIs
32 LITERALS
20 BLANK NODES